Solvay Pharma India Ltd(merged)
₹
None%
- close price
About
Solvay Pharma India Limited(merged), incorporated in India, listed on the Bombay Stock Exchange, the company is engaged in tablets, capsules, syrups, etc.
[
edit about
]
[
add key points
]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE 51.2 %
- ROE 34.4 %
- Face Value ₹
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 22.8% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
- Company has been maintaining a healthy dividend payout of 31.1%
- Debtor days have improved from 25.1 to 18.6 days.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Raw PDF |
Profit & Loss
Figures in Rs. Crores
Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | |
---|---|---|---|---|---|---|
130 | 144 | 167 | 202 | 242 | 295 | |
99 | 113 | 123 | 156 | 183 | 222 | |
Operating Profit | 30 | 31 | 44 | 46 | 59 | 73 |
OPM % | 23% | 21% | 26% | 23% | 24% | 25% |
3 | 4 | 4 | 6 | 5 | 6 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 5 | 5 | 5 | 1 | 3 | 3 |
Profit before tax | 28 | 30 | 43 | 50 | 61 | 76 |
Tax % | 36% | 37% | 34% | 35% | 34% | 33% |
18 | 19 | 28 | 33 | 40 | 51 | |
EPS in Rs | ||||||
Dividend Payout % | 17% | 22% | 72% | 27% | 41% | 25% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 21% |
TTM: | 22% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 23% |
3 Years: | 22% |
TTM: | 30% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 32% |
3 Years: | 33% |
Last Year: | 34% |
Balance Sheet
Figures in Rs. Crores
Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | |
---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 |
Reserves | 63 | 77 | 82 | 104 | 125 | 161 |
0 | 0 | 0 | 0 | 0 | 0 | |
21 | 26 | 32 | 48 | 41 | 54 | |
Total Liabilities | 89 | 108 | 119 | 157 | 172 | 220 |
10 | 7 | 4 | 2 | 38 | 36 | |
CWIP | 0 | 0 | 0 | 35 | 0 | 0 |
Investments | 7 | 14 | 40 | 17 | 16 | 37 |
72 | 87 | 74 | 103 | 118 | 148 | |
Total Assets | 89 | 108 | 119 | 157 | 172 | 220 |
Cash Flows
Figures in Rs. Crores
Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | |
---|---|---|---|---|---|---|
17 | 15 | 27 | -7 | 70 | 27 | |
-6 | -6 | -24 | 1 | -9 | -17 | |
-3 | -4 | -19 | -12 | -15 | -12 | |
Net Cash Flow | 8 | 6 | -17 | -17 | 46 | -2 |
Ratios
Figures in Rs. Crores
Dec 2005 | Dec 2006 | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | |
---|---|---|---|---|---|---|
Debtor Days | 36 | 36 | 36 | 33 | 24 | 19 |
Inventory Days | 113 | 136 | 118 | 240 | 116 | 165 |
Days Payable | 94 | 107 | 89 | 134 | 74 | 87 |
Cash Conversion Cycle | 56 | 65 | 66 | 140 | 66 | 96 |
Working Capital Days | 44 | 47 | 34 | 82 | 33 | 49 |
ROCE % | 39% | 51% | 51% | 50% | 51% |
Documents
Annual reports
No data available.